BSECompany Update10 Oct 2026 · 10 Oct 2026, 11:38 am
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30-09-2026
Kwality Pharmaceuticals Ltd · 539997
✦ AI Summary
Kwality Pharmaceuticals Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialization of securities up to September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
43ee4dc1-3263-4571-80f9-3f9ed23adc40.pdf
View document text
CIN No. L24232PB1983PLC005426 GST No. 03AAACK6458M1ZB Phone : 91-8558820862 (Accounts)
8 D.L. No. 1800-0SP, 1804-B I.E. Code No. 1293001210 : 91-8558820863 (Admin.)
: 91-9915743720 (Exports)
K1VALITY PHARMACEUTICALS LIMITED M.D. Mobile: 91-9814071215, 9814052314
E-mail : export@kwalitypharma.com
Regd. Office: Village Nag KaIan, Majitha Road, Amritsar - 143 601 (INDIA) ramesh@kwalitypharma.com
Date: October 10, 2026
The Department of Corporate services
BSE Limited
Phiroze Jeejeebhoy Towers,
25th Floor, Dalai Street,
Mumbai-400001
Scrip Code: 539997
Subject: Certificate under Regulation 74(5) of SEB1 (Depositories and Participants.'
Regulations. 2018 for the Quarter Ended September 30. 2026
Dear Sir/Madam,
With reference to the captioned subject, please find enclosed herewith confirmation
certificate issued in accordance with Regulation 74(5) of the SEBI (Depositories and
Participants) Regulations, 2018 for the quarter ended September 30, 2026 as received
from Bigshare Services Private Limited, the Registrar and Share Transfer Agent of the
Company.
Please take the same on records.
Yours Faithfully
For Kwality Pharmaceuti
P' 11-
Gurpreet Kaur
Company Secretary & Compliance
Ref No. BSS/74(5)
Date: 09/10/2026
KWALITY PHARMACEUTICALS LTD
VILLAGE NAGKALAN
MAJITHA ROAD
AMRITSAR
PUNJAB AMRITSAR- 143601
Dear Sir/Madam,
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations,
2018 for the quarter ended 30th September 2026
Ref: NSDL/CIR/II/5/2019 dated 25th January 2019 DSL/OPS/RTA/POLICY/2019/14 dated 25th
January 2019. SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24/01/2019
In reference to the above – captioned regulation we hereby confirm that the securities received from the
depository Participants for dematerialization up to 30th September 2026 were confirmed
(accepted/rejected) to the depositories by us and that securities comprised in the said certificates have
been listed on the stock exchange where the earlier issued securities are listed.
We hereby confirm that the security certificates received for dematerialization have been mutilated &
cancelled after due verification by the depository Participant and the name of the depositories have been
substituted in register of members as registered owner within 15 days of receipt of certificate of
securities.
We request you to kindly take note of the above in your records.
This is for your information.
Thanking You,
Yours faithfully,
For Bigshare Services Pvt. Ltd.,
Sandeep More
Authorised Signatory